F

FutureChem Co Ltd
KOSDAQ:220100

Watchlist Manager
FutureChem Co Ltd
KOSDAQ:220100
Watchlist
Price: 15 350 KRW -2.85% Market Closed
Market Cap: 339.2B KRW
Have any thoughts about
FutureChem Co Ltd?
Write Note

FutureChem Co Ltd
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

FutureChem Co Ltd
Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
F
FutureChem Co Ltd
KOSDAQ:220100
Operating Expenses
-â‚©10.8B
CAGR 3-Years
-5%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Operating Expenses
-â‚©786.8B
CAGR 3-Years
-73%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
Knotus Co Ltd
KOSDAQ:278650
Operating Expenses
-â‚©37.7B
CAGR 3-Years
-3%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
S
ST Pharm Co Ltd
KOSDAQ:237690
Operating Expenses
-â‚©70.8B
CAGR 3-Years
-14%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Operating Expenses
-â‚©118.3B
CAGR 3-Years
-10%
CAGR 5-Years
-29%
CAGR 10-Years
-29%
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Operating Expenses
-â‚©18.6B
CAGR 3-Years
2%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
No Stocks Found

FutureChem Co Ltd
Glance View

Market Cap
339.2B KRW
Industry
Life Sciences Tools & Services

FutureChem Co., Ltd. engages in the manufacture of medical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2015-08-13. Co.,Ltd is a Korea-based company principally engaged in the manufacture and distribution of radiopharmaceuticals. The firm manufactures radiopharmaceuticals including radiopharmaceuticals for diagnosis of various cancers such as lung cancer and for the early diagnosis of Parkinson's disease and Alzheimer's disease. The firm also produces medical automation modules such as cubes and disposable goods including disposable cassettes, reagent kits, radio-caps and kryptofix kits; productions of photon emission tomography (PET) and single photon emission computed tomography (SPECT) precursors for radiopharmaceuticals and other chemicals such as metal chelating agents, fluorescence probes, peptides.

Intrinsic Value
1 127.84 KRW
Overvaluation 93%
Intrinsic Value
Price
F

See Also

What is FutureChem Co Ltd's Operating Expenses?
Operating Expenses
-10.8B KRW

Based on the financial report for Jun 30, 2024, FutureChem Co Ltd's Operating Expenses amounts to -10.8B KRW.

What is FutureChem Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
0%

Over the last year, the Operating Expenses growth was 26%. The average annual Operating Expenses growth rates for FutureChem Co Ltd have been -5% over the past three years .

Back to Top